PROFOUND MEDICAL CORP. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
PROFOUND MEDICAL CORP. (PROF) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 113.07 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-08-06
- PROFOUND MEDICAL CORP. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-06-30 was 97.53K shares, a 840.73% increase year-over-year.
- PROFOUND MEDICAL CORP. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-03-31 was 15.54K shares, a 91.70% decline year-over-year.
- PROFOUND MEDICAL CORP. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-12-31 was 5.71K shares.
- PROFOUND MEDICAL CORP. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-09-30 was 36.89K shares.
- PROFOUND MEDICAL CORP. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 240.28K shares, a 94.63% increase from fiscal 2024.
- PROFOUND MEDICAL CORP. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 123.46K shares, a 97.64% increase from fiscal 2023.
- PROFOUND MEDICAL CORP. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 62.47K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 97.53K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 113.07K shares 10-Q · filed 2026-08-06 | 118.78K shares derived: sum of 3 quarters · filed 2026-08-06 | 155.67K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 15.54K shares 10-Q · filed 2026-05-07 | 21.25K shares derived: sum of 2 quarters · filed 2026-05-07 | 58.13K shares derived: sum of 3 quarters · filed 2026-05-07 | 68.50K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 5.71K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 42.60K shares derived: sum of 2 quarters · filed 2026-03-05 | 52.96K shares derived: sum of 3 quarters · filed 2026-03-05 | 240.28K shares 10-K · filed 2026-03-05 |
| 2025-09-30 | 36.89K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 47.26K shares derived: sum of 2 quarters · filed 2025-11-13 | 234.57K shares 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 10.37K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 197.68K shares 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | 187.32K shares 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | 123.46K shares 10-K · filed 2026-03-05 | |||
| 2023-12-31 | 62.47K shares 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |